Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Bressler

Showing results (41-50 of 191) with videos related to

Pageof 20
Sort By:
World Journal of Gastroenterology|January 14, 2014
Time of infliximab therapy initiation and dose escalation in Crohn's diseaseMindy C W Lam, Terry Lee, Kenneth Atkinson, et al.
British Journal of Clinical Pharmacology|June 16, 2009
Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN alpha-2a (40KD) (PEGASYS)Brian Bressler, Ka Wang, Joseph F Grippo, et al.
World Journal of Gastroenterology|September 11, 2014
Impact of medical therapy on patients with Crohn's disease requiring surgical resectionY T Nancy Fu, Thomas Hong, Andrew Round, et al.
World Journal of Hepatology|November 2, 2013
Severe cholestasis due to adalimumab in a Crohn's disease patientEdward Kim, Brian Bressler, David F Schaeffer, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|November 29, 2021
An automated mass spectrometric blood test for therapeutic drug monitoring of infliximabJ Grace van der Gugten, Brian Bressler, Mari L DeMarco
Canadian Journal of Gastroenterology & Hepatology|September 18, 2014
Response to letter to the editorBrian Bressler, Shane Devlin, Charles Bernstein, et al.
Canadian Journal of Gastroenterology & Hepatology|July 1, 2015
Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel diseaseBrian Bressler, Remo Panaccione, Richard N Fedorak, et al.
The Cochrane Database of Systematic Reviews|December 3, 2015
Etrolizumab for induction of remission in ulcerative colitisGreg Rosenfeld, Claire E Parker, John K MacDonald, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2011
Oral contraceptives and the risk of gallbladder disease: a comparative safety studyMahyar Etminan, Joseph A C Delaney, Brian Bressler, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF ExposureBrian Bressler, Martin Williamson, Bernie Sattin, et al.
Pageof 20

Showing results (41-50 of 191) with videos related to

Sort By:
Pageof 20
World Journal of Gastroenterology|January 14, 2014
Time of infliximab therapy initiation and dose escalation in Crohn's diseaseMindy C W Lam, Terry Lee, Kenneth Atkinson, et al.
British Journal of Clinical Pharmacology|June 16, 2009
Pharmacokinetics and response of obese patients with chronic hepatitis C treated with different doses of PEG-IFN alpha-2a (40KD) (PEGASYS)Brian Bressler, Ka Wang, Joseph F Grippo, et al.
World Journal of Gastroenterology|September 11, 2014
Impact of medical therapy on patients with Crohn's disease requiring surgical resectionY T Nancy Fu, Thomas Hong, Andrew Round, et al.
World Journal of Hepatology|November 2, 2013
Severe cholestasis due to adalimumab in a Crohn's disease patientEdward Kim, Brian Bressler, David F Schaeffer, et al.
Clinical Mass Spectrometry (Del Mar, Calif.)|November 29, 2021
An automated mass spectrometric blood test for therapeutic drug monitoring of infliximabJ Grace van der Gugten, Brian Bressler, Mari L DeMarco
Canadian Journal of Gastroenterology & Hepatology|September 18, 2014
Response to letter to the editorBrian Bressler, Shane Devlin, Charles Bernstein, et al.
Canadian Journal of Gastroenterology & Hepatology|July 1, 2015
Clinicians' guide to the use of fecal calprotectin to identify and monitor disease activity in inflammatory bowel diseaseBrian Bressler, Remo Panaccione, Richard N Fedorak, et al.
The Cochrane Database of Systematic Reviews|December 3, 2015
Etrolizumab for induction of remission in ulcerative colitisGreg Rosenfeld, Claire E Parker, John K MacDonald, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|April 20, 2011
Oral contraceptives and the risk of gallbladder disease: a comparative safety studyMahyar Etminan, Joseph A C Delaney, Brian Bressler, et al.
Journal of the Canadian Association of Gastroenterology|July 12, 2019
Real World Effectiveness of Golimumab Therapy in Ulcerative Colitis Regardless of Prior TNF ExposureBrian Bressler, Martin Williamson, Bernie Sattin, et al.
Pageof 20